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Accepted 27 November 2014We hypothesized that the maternal obesity initiates metabolic disorders associated with
oxidative stress in the liver of offspring since early life. Mouse's mothers were assigned into
2 groups according to the diet offered (n = 10 per group): standard chow (SC) or high-fat diet
(HF). The results revealed that HF offspring had an increase in bodymass at day 10 (+25%, P <
.05) and in glucose levels (+25%, P < .0001). Hepatic triacylglycerolwas increased in HF offspring
at day 1 and day 10 comparedwith SC offspring (+30%, P < .01 and +40%, P < .01) aswas hepatic
steatosis (+110%, P < .001; +145%, P< .0001). Fatty acid synthasewas increased inHFoffspring at
day 1 (+450%, P < .01) and peroxisome proliferator activator receptor-γ was elevated at day 1
and day 10 (+140%, P < .01; +2741%, P < .01). Peroxisome proliferator activator receptor-α was
diminished in HF offspring at day 10 compared with SC offspring (−100%, P < .01).
Moreover, carnitine palmitoyl-CoA transferase-1 was decreased in HF offspring at day 1
and day 10 (−80%, P < .01; −60%, P < .05). In the HF offspring (comparedwith the SCoffspring),
the catalase and the superoxide dismutase were significantly lower in both days 1 and 10 (P <
.05). In 10-day-old offspring, glutathione peroxidase 1 and glutathione reductasewere lower in
HF offspring than in SC offspring (P < .0001). Our findings suggest that the maternal obesity in
mice induces an early oxidative dysfunction coupled with hepatic steatosis and might
contribute to progressive liver injury later in life.
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Mice1. Introduction
Obesity has become a serious public health problem, affecting
individuals of all age ranges, particularly women in the repro-
ductive stage, setting forth a deleterious maternal nutritional
status [1,2].
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rved.delivery of nonesterified fatty acids from adipose tissue to the
liver tissue [3]. This established framework has implications in
the pathogenesis of liver steatosis because the input of lipid
exceeds the capacity of fatty acids oxidation and/or export.
Although this condition is initially asymptomatic and benign,
NAFLD is the elementary injury for the development of severe
pathology such as liver cirrhosis and hepatocellular carcinoma,
which may be associated with increased oxidative stress [4,5].itoyl-CoA transferase; DIO, diet-induced obesity; FAS, fatty acid
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Table 1 – Ingredient and proximate analysis of diets fed
to mice
Nutrients (g/kg) SC HF
Casein 190.00 230.00
Corn starch 539.50 299.50
Sucrose 100.00 100.00
Soybean oil 70.00 70.00
Lard – 200.00
Fiber 50.00 50.00
Vitamin mixture (mg) 10.00 10.00
Mineral mixture (mg) 35.00 35.00
Cysteine 3.00 3.00
Choline 2.50 2.50
Antioxidants 0.01 0.01
Total mass (g) 1.00 1.00
Energy (kcal/kg) 3.95 4.95
Carbohydrates (%) 64.00 32.00
Protein (%) 19.00 19.00
Lipids (%) 17.00 49.00
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important target in the investigation of metabolic disorders in
the offspring of obesewomen, corroborated by the fact that this
organelle constitutes a critical site of energy metabolism [6].
Accordingly, livermitochondrial dysfunctionmaybe associated
with reduced β-oxidation of fatty acids and decreases in
cytochrome C and carnitine palmitoyl-CoA transferase (CPT)-1
enzyme [7]. In addition, mitochondrial dysfunction leads to
excessive lipids in the liver and may promote the formation of
reactive oxygen species (ROS), leading to lipid peroxidation,
inflammation, and fibrosis [8].
Previous data support the concept that the offspring of diet-
induced obese (DIO) dams have adverse metabolic program-
ming and develop overweight/obesity and dyslipidemia in
adulthood [9,10]. However, such offspring have disrupted liver
metabolism and develop NAFLD prior to any notable differ-
ences in body mass (BM) or body composition [11], which is a
phenomenon known as “liver metabolic imprinting” [12,13].
Nevertheless, it is important to consider whether the insult in
the liver due to maternal obesity occurs sufficiently early to be
detected in the offspring and to allowa preventive intervention.
Although the literature reported a different model of
lipotoxity in the fetal liver using nonhuman primates of
obese mothers [14], the field of study is considerably complex
andmerits further studies.Wewere particularly interestedhere
in assessing the hepatic insult in the very early life of the
progeny of DIOmothers, observing the association between the
liver metabolism and oxidative stress.2. Methods and materials
2.1. Animals and diet
This study was performed in strict accordance with the
recommendations of the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Committee on the Ethics of
Animal Experiments of the State University of Rio de Janeiro
(Protocol CEUA 053/10), and all efforts were made to
minimize suffering.
Animals were maintained under controlled temperature
conditions of 20 ± 2°C; humidity 60% ± 10% and 12:12-hour
dark/light cycle, and they had free access to food and water.
Thus, 4-week-old female C57BL/6 mice were randomly
assigned into 2 groups according to the diet offered (n = 10
per group): standard chow (SC) or high-fat diet (HF). In the SC
group, 64% of energy was derived from carbohydrates, 19% of
energy from protein, and 17% of energy from lipids. In the HF
group, 32% of energy was derived from carbohydrates, 19% of
energy from protein, and 49% of energy from lipids. The
vitamin andmineral contents of both diets were identical and
followed the standards for rodent diets recommended by the
American Institute of Nutrition to support growth during the
pregnancy, lactation, and postweaning periods (Table 1) [14].
After 8 weeks on the 2 diets, at 12 weeks of age, SC and HF
fed females were mated with SC-fed C57BL/6 male mice of the
same age and the females remained on their experimental
diets throughout pregnancy and lactation. Thus, day 0 of
gestation was determined by observing the formation of avaginal plug. Pups were divided according to the maternal
diet: SC pups were birthed from dams fed SC diet, whereas HF
pups were birthed from dams fed HF diet. Onemale from each
litter was randomly assigned to each of the experimental
groups (the sex was assigned according to the anogenital
distance) [15] and was studied at postnatal day 1 (the
birthday) and at postnatal day 10. Fig. 1 details the design of
the formation of the groups. We adjusted the litters that were
followed until day 10 randomly to 7 pups to provide adequate
and standardized nutrition in the period. As a consequence,
pups were divided according to the maternal diets into 4
groups (n = 5 each group):
1. SC offspring postnatal day 1
2. HF offspring postnatal day 1
3. SC offspring postnatal day 10
4. HF offspring postnatal day 10
The BM of the mothers was measured weekly, during the 8
weeks before pregnancy. The BM of the offspring was
measured at day 1 and postnatal day 10.
2.2. Euthanasia and tissue extraction
The newborns were rapidly decapitated, and the blood was
collected immediately. At day 10, puppies were separated
from their mothers 1 hour prior to decapitation, then blood
was collected and the glycemia was measured (Accu-Check
Active glucometer; Roche Applied Science, São Paulo, Brazil),
and the liver was carefully and rapidly dissected, weighed,
and made to further analyzes. Various fragments were frozen
for molecular and biochemical analyzes or immersed in
freshly prepared fixative (1.27 mol/L formaldehyde in 0.1 M
phosphate buffer, pH 7.2) for 48 h at room temperature.
2.3. Liver structure and biochemistry
The fixed liver fragments were then embedded in Paraplast
Plus (Sigma-Aldrich Co, St Louis, MO, USA), sectioned at a
nominal thickness of 5 μm, and stained with hematoxylin and
eosin. At least 5 microscopic fields per animal were analyzed
Table 2 – RT-qPCR primers and respective sequences
Name 5-3′ Primers
FAS FW CACCCACTGGAAGCTGGTAT
RV TCGAGGAAGGCACTACACCT
CPT-1 FW AAGGAATGCAGGTCCACATC
RV CCAGGCTACAGTGGGACATT
PPARα FW TCGAGGAAGGCACTACACCT
RV TCTTCCCAAAGCTCCTTCAA
PPARγ2 FW ACGATCTGCCTGAGGTCTGT
RV CATCGAGGACATCCAAGACA
MnSOD FW GGTCTCCAACATGCCTCTCT
RV AACCATCCACTTCGAGCAGA
GPx1 FW TCTGCAGATCGTTCATCTCG
RV GTCCACCGTGTATGCCTTCT
CAT FW CAAGTTTTTGATGCCCTGGGT
RV ACATGGTCTGGGACTTCTGG
GSR FW CAGCATAGACGCCTTTGACA
RV CACGACCATGATTCCAGATG
β-Actin FW CTCCGGCATGTGCAA
RV CCCACCATCACACCCT
Fig. 1 – Sampling design for the study. For the composition of
experimental groups, 1male pup of each litterwas considered
in this study, totaling a sample of 5 animals per group.
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90i microscope with DS-Ri1 camera, Tokyo, Japan). We used a
test system made up of 36 test points (PT) produced with the
STEPanizer Web-based system (www.stepanizer.com) put
over the images for the analysis. Briefly, we estimated the
volume density of liver steatosis using the point-counting
technique: Vv[liver, steatosis] = Pp[steatosis]/PT[liver] (Vv is
volume density and Pp is the number of points that hit the fat
drops into the hepatocyte) [16,17].
The hepatic triacylglycerol (TAG) levels were measured in
50 mg of frozen liver tissue placed in an ultrasonic processor
with 1mL of isopropanol. The homogenate was centrifuged at
2000g, and 5 μL of the supernatant was used to measure TAG
with a kit and an automated spectrophotometer (Bioclin
System II; Quibasa Ltda, Belo Horizonte, Brazil).
2.4. Antioxidants enzymes activity
Catalase (CAT), glutathione peroxidase (GPx), and manganese
superoxide dismutase (MnSOD) activities were measured in
the liver homogenate of the 10-day-old offspring. Catalase
activity was measured in terms of the rate of decrease in
hydrogen peroxide concentration at 240 nm [18]. Glutathione
peroxidase activity was measured by monitoring the oxida-
tion of NADPH at 340 nm in the presence of hydrogen
peroxide [19]. Manganese superoxide dismutase activity was
assayed by measuring the inhibition of adrenaline auto-
oxidation at 480 nm [20]. The activity of antioxidant enzymes
was expressed in U/mg protein.
2.5. Real-time quantitative polymerase chain reaction
Total RNA was extracted from approximately 50 mg of liver
tissue using Trizol reagent (Invitrogen, Carlsbad, CA, USA).
RNA amount was determined using Nanovue (GE Healthcare
Bio-Sciences Corp., Piscataway, NJ, USA) spectroscopy, and 1μg of RNA was treated with DNAse I (Invitrogen). Synthesis of
the first-strand complementary DNA (cDNA) was performed
using Oligo (dT) primers for messenger RNA (mRNA) and
Superscript III reverse transcriptase (both Invitrogen). Quan-
titative real-time polymerase chain reaction (RT-qPCR) was
performed using a Biorad CFX96 cycler and the SYBR Green
mix (Invitrogen). Table 2 shows the primers for qPCR as they
were designed using the Primer3 online software.
Endogenous control β-actin was used to normalize the
expression of the selected genes. The efficiencies of RT-qPCR
for the target gene and the endogenous control were
approximately equal and were calculated through dilution
series of cDNA. Real-time PCR reactions were conducted as
follows: after a predenaturation and polymerase-activation
program (4 minutes at 95°C), 44 cycles, each cycle consisting
of 95°C for 10 seconds and 60°C for 15 seconds, were followed
by a melting curve program (60°C-95°C with a heating rate of
0.1°C/s). Negative controls consisted of wells in which cDNA
was substituted for deionized water. The relative expression
ratio of mRNA was calculated by the equation 2−ΔΔCt, in which −
ΔCT expresses the difference between the number of cycles (CT)
of the target genes and the endogenous control. Concerning lipid
metabolism, we analyzed fatty acid synthase (FAS), peroxisome
proliferator activator receptor (PPAR)-γ, PPAR-α, and CPT-1.
Regarding the antioxidant enzymes, we analyzed MnSOD,
GPx-1, and glutathione reductase (GRS).
2.6. Statistical analyses
The data are expressed as the means and the associated
SEMs. Differences were analyzed using one of the tests:
unpaired Student t test (to compare SC vs HF: the mothers
and to compare the offspring [antioxidants enzymes in day
10]) or 1-way analysis of variance (ANOVA) followed by the
Holm-Sydak post hoc test. A P value ≤ .05 was considered
statistically significant (GraphPad Prism version 6.05 for
Windows; GraphPad Software, La Jolla, CA, USA).
Fig. 2 – Body mass. Data are presented as means and SEMs
(n = 5 per group). Significant differences are indicated (1-way
ANOVA and post hoc Holm-Sydak tests). Symbols:
†, significantly different from SC counterpart; ‡, different
from day 1.
Table 3 – Two-way ANOVA analyzing HF and age
Two-way
ANOVA
% of the variation and significance test
Interaction Diet Age
% P % P % P
BM 1.63 ≤.0001 2.25 ≤.0001 95.65 ≤.0001
CAT 1.24 NS 67.76 ≤.0001 1.38 NS
CPT-1 0.38 NS 62.94 ≤.0001 2.30 NS
FAS 4.29 NS 52.22 ≤.0001 10.91 ≤.05
Glycemia 2.59 .01 4.81 ≤.001 88.77 ≤.0001
GPx-1 22.87 ≤.0001 22.87 ≤.0001 39.68 ≤.0001
GRS 12.36 NS 34.81 ≤.01 0.97 NS
Hepatic TAG 0.29 NS 69.66 ≤.0001 0.44 NS
Liver steatosis 0.87 NS 79.23 ≤.0001 0.13 NS
MnSOD 4.86 NS 62.47 ≤.0001 9.54 ≤.05
PPAR-α 4.69 NS 55.04 ≤.001 2.53 NS
PPAR-γ 0.057 NS 61.51 ≤.0001 11.73 ≤.05
Fig. 3 – Blood glucose levels. Data are presented as means
and SEMs (n = 5 per group). Significant differences are
indicated (1-way ANOVA and post hoc Holm-Sydak tests).
Symbols: †, significantly different from SC counterpart;
‡, significantly different from day 1.
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3.1. Maternal BM
The BM did not show a significant difference comparing the
SC damswith the HF damswhen the study started (SC: 10.46 ±
0.43 g vs HF: 10.39 ± 0.34 g). However, after 8 weeks in the
experimental diets (before pregnancy), we found a greater BM
in the HF dams than in the SC dams (SC: 22.88 ± 0.48 g vs HF:
29.13 ± 0.22 g; +27%, P < .0001).
3.2. Body mass and glucose levels
No BM difference was found in comparing the SC offspring
with the HF offspring at birth. However, at 10 days of age, the
HF offspring presented greater BM than the SC offspring (25%
greater, P < .05). Comparing the BM at birth with the BM at 10
days of life, there was an increase of 300% in the SC offspring
(P < .0001) and an increase of 355% in the HF offspring (P <
.0001; Fig. 2).
The diet accounted for 2.25% of the variance of the BM (P <
.0001, 2-way ANOVA). The age of the pups accounted for
95.65% of the variance of the BM (P < .0001, 2-way ANOVA).
Moreover, there was a significant interaction between diet
and age accounting for 1.63% of the total variance (P < .0001,
2-way ANOVA; Table 3).
At 10 days of age, the blood glucose level was higher in the
HF offspring than in the SC offspring (25% higher, P < .0001).
Comparing the blood glucose level at day 1 with day 10,
increases of 100% in the SC offspring (P < .0001) and of 140% in
the HF offspring (P < .0001) were observed (Fig. 3).
The diet accounted for 4.81% of the variance of the blood
glucose (P < .001, 2-way ANOVA). The age of the pups
accounted for 88.77% of the variance of the blood glucose (P
< .0001, 2-way ANOVA). There was a significant interactionbetween diet and age accounting for 2.59% of the total
variance (P < .05, 2-way ANOVA; Table 3).
3.3. Hepatic TAG and steatosis
The hepatic TAG content was higher in the HF offspring at
both ages in comparison with SC offspring (day 1, +30%, P <
.01; day 10, +40%, P < .01). Hepatic steatosis was also greater in
the HF offspring than in the SC offspring at both ages (day 1,
+110%, P < .001; day 10, +145%, P < .0001; Fig. 4).
The diet accounted for 69.66% of the variance of the
hepatic TAG (P < .001, 2-way ANOVA), and the diet accounted
for 79.23% of the variance of the hepatic steatosis (P < .0001, 2-
way ANOVA; Table 3).
A strong and significant correlation was found between
hepatic TAG levels and hepatic steatosis in the HF offspring at
both ages studied (day 1: r = 0.91, P < .05; day 10: r = 0.92, P <
.05). This correlation was not demonstrated in the SC
offspring (Fig. 5).
Fig. 4 – Photomicrographs of liver tissue (hematoxylin-eosin stain, samemagnification for all photomicrographs): (A) SC day 1,
(B) HF day 1, (C) SC day 10, (D) HF day 10, (E) TAG content, and (F) volume density of steatosis. Data are presented as means and
SEMs (n = 5 per group). Significant differences are indicated (1-way ANOVA and post hoc Holm-Sydak tests). Symbols: †,
significantly different from SC counterpart.
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CAT activity: there was no difference between the SC
offspring and the HF offspring in the postnatal day 10 (SC:
0.037 ± 0.002 U/mg protein vs HF: 0.049 ± 0.008 U/mg protein;
P > 0.05).
GPx-1 activity: there was no difference between the SC
offspring and theHF offspring in the postnatal day 10 (SC: 9.04 ±
1.20 U/mg protein vs HF: 9.24 ± 0.90 U/mg protein; P > 0.05).
MnSOD activity: in postnatal day 10, the MnSOD activity
was lower in the HF offspring than in the SC offspring (HF:
17.34 ± 4.78 U/mg protein vs SC: 51.32 ± 13.21 U/mg protein;
P < .05).3.5. Liver RT-qPCR
As shown in Fig. 6, we observed 2 patterns ofmRNA expression
in both age groups studied: FAS and PPAR-γ valueswere higher,
and CPT-1 and PPAR-α values were lower in the HF offspring
than in the SC offspring.
Fatty acid synthase was 450% higher (P < .01) in the HF
offspring than in the SC offspring at both ages. Peroxisome
proliferator activator receptor-γ was 140% higher in the HF
offspring than in the SC offspring at day 1 (P < .01) and 2700%
higher at day 10 (P < .01).
The diet accounted for 52.22% of the variance of the mRNA
expression of FAS (P < .001, 2-way ANOVA). The age of the
Fig. 5 – Correlation of liver steatosis (variable y) and liver TAG
levels (variable x). The coefficient of correlation of Pearson,
r, and P values are indicated.
Fig. 6 – RelativemRNA expression of FAS, PPAR-γ, CPT1, and PPA
Significant differences are indicated (1-way ANOVA and post ho
relative expression. C, CPT-1 relative expression. D, PPAR-α rela
normalize the expression of the selected genes. Symbols: †, sign
different from day 1.
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expression (P < .05, 2-way ANOVA). The diet accounted for
61.51% of the total variance of the mRNA PPAR-γ expression
(P < .001, 2-way ANOVA). The age of the pups accounted for
11.73% of the variance of the PPAR-γ expression (P < .05, 2-way
ANOVA; Table 3).
Compared with the SC offspring, the HF offspring demon-
strated lower PPAR-α (day 10: 100% lower, P < .01) and CPT-1
(day 1: 80% lower, P < .01; day 10: 60% lower, P < .05).
The diet accounted for 55.04% of the variance of the mRNA
PPAR-α expression (P < .001, 2-way ANOVA). Moreover, the
diet accounted for 62.94% of the variance of the mRNA CPT-1
expression (P < .0001, 2-way ANOVA; Table 3).
As shown in Fig. 7, we saw one pattern of mRNA
expression in both age groups studied: CAT, MnSOD, GPx-1,
and GRS were lower in the HF offspring than in the SC
offspring; however, the GRS mRNA expression at day 10 was
not different between the HF and the SC groups.
Catalase was 80% lower at day 1 (P < .01) and day 10 (P < .01)
in the HF offspring than in the SC offspring. Manganese
superoxide dismutase was 90% lower at day 1 (P < .001), and it
was 100% lower at day 10 (P < .05) in the HF offspring than inR-α. Data are presented asmeans and SEMs (n = 5 per group).
c Holm-Sydak tests). A, FAS relative expression. B, PPAR-γ
tive expression. An endogenous control (β-actin) was used to
ificantly different from SC counterpart; ‡, significantly
Fig. 7 – Relative mRNA expression of CAT, MnSOD, GPx-1 and GRS An endogenous control (β-actin) was used to normalize the
expression of the selected genes. Data are presented asmeans and SEMs (n = 5 per group). Significant differences are indicated
(1-way ANOVA and post hoc Holm-Sydak tests). A, CAT relative expression. B, MnSOD relative expression. C, GPx-1 relative
expression. D, GRS relative expression. Symbols: †, significantly different from SC counterpart; ‡, significantly different from
day 1.
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at both ages (P < .0001) in the HF offspring than in the SC
offspring. The GRS was 80% lower at day 1 (P < .05) but not at
day 10 in the HF offspring than in the SC offspring.
The mRNA CAT expression: the diet accounted for 67.76%
of the variance (P < .0001). The mRNA MnSOD expression: the
diet accounted for 62.47% of the variance (P < .0001). The
mRNA MnSOD expression: the age of the pups accounted for
9.54% of the variance (P < .05). The mRNA GPx-1 expression:
the diet accounted for 22.87% of the variance (P < .001), the age
of the pups accounted for 39.68% of the variance (P < .0001),
and there was an interaction between diet and age accounting
for 22.87% of the total variance (P < .001). The mRNA GRS
expression: the diet accounted for 34.81% of the variance (P <
.05; Table 3).4. Discussion
The current study showed deleterious hepatic effects and
hyperglycemia in very young mice that were the offspring of
DIO dams. These deleterious effects were observed in BM,
blood glucose levels, hepatic TAG and steatosis, high mRNA
expression of lipogenic enzymes, and low mRNA expressionof β-oxidation enzymes. In addition, we noted a disruption in
the activity and mRNA expression of antioxidant enzymes
since the early days after birth.
Previous studies have shown a substantial BM gain
associatedwith impaired glucose tolerance, insulin resistance
(IR) and hepatic steatosis in adulthood among the offspring of
DIO maternal animal models [9,21]. In the current study, the
obesity of the maternal mice lasted throughout gestation and
the first ten days of offspring life. It is important to highlight
that the duration of exposure, energy from lipids, and diet
composition result in different offspring phenotypes [22]. The
effect of maternal nutritional status during critical periods of
development upon consequences in later life of the offspring
have been reported [23,24]. Excessive gestational weight gain
during pregnancy in a pig model led to early indications of
metabolic syndrome in offspring that were further promoted
by a high-energy postweaning diet [25]. Experimental data of
our group have shown differences in the offspring responses
when the programming wasmade during gestation only, or in
the lactation period. For example, considering the period the
mothers received an HF diet as G (the gestational time), L (the
lactation time), and PW the postweaning time (offspring were
maintained in an HF diet), the G offspring showed IR and
lower glucose transporter-2 protein expression. Hepatic steatosis
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sterol regulatory element-binding proteins-1c expression was
higher in G, GL, and GL/PW offspring [26].
In the present study, we showed that the offspring of the
obese dams were born with already demonstrable hepatic
insults and glucose intolerance, which are considered essential
to the development of highly seriousmetabolic alterations later
in life [27,28]. Nonesterified fatty acids and inflammatory
cytokines are also considered to be insulting to offspring and
are usually found at higher concentrations in the offspring of
DIOmothers than in the offspring of nonobesemothers [22,26].
However, a limitation of the study was the impossibility of
measuring nonesterified fatty acid because of the very low
blood volume of the animals in the ages studied.
A relevant finding in the present study was that liver
damage in very young offspring was accompanied by a
change in mRNA expressions of transcription factors and
enzymes related to lipogenesis and β-oxidation. Similarly, the
mRNA expression of antioxidant enzymes was diminished in
HF offspring compared with SC offspring in early life. The HF
offspring showed an increase in PPAR-γ mRNA expression
with a concomitant decrease in PPAR-α mRNA expression.
Peroxisome proliferator activator receptor-γ is considered to
be a major transcriptional regulator of adipogenesis and plays
an important role in the process of lipid storage [29]. In an
experimental study, the offspring of DIO maternal animals
exhibited a decrease in PPAR-γ mRNA expression and a
concomitant increase in PPAR-α mRNA expression when
they were treated with bezafibrate, improving liver damage
[21]. Literature describes that the exposure to maternal obesity
leads to decreased mRNA expression of PPAR-α genes prior to
the development of adiposity gain [30], which agrees with our
results in the very young offspring of DIO maternal mice. In
addition, our findings agree with data reporting that a
developing fetus is highly susceptible to excess lipids, and this
may increase the risk of NAFLD [31].
A recent study of the 8-week-old offspring of obese dams
showed that the offspring were hyperinsulinemic with
significantly increased hepatic oxidative damage markers
and with reduced levels of the antioxidant enzyme GPx-1. In
addition, mitochondrial complex I and II activities were
elevated, whereas the levels of mitochondrial cytochrome C
were significantly reduced, and glutamate dehydrogenase
was increased, suggesting mitochondrial dysfunction. Off-
spring of obese dams also had significantly greater hepatic
lipid content, associated with increased levels of PPAR-γ and
reduced triglyceride lipase. Liver glycogen and protein con-
tent were concomitantly reduced in the offspring of obese
dams [11].
We observed a decrease in mRNA expression of CPT-1 in
both ages in this study. Carnitine palmitoyl-CoA transferase-1
is a regulatory enzyme and a target gene of PPAR-α in the
mitochondria that transfers fatty acids from the cytosol to the
mitochondria prior to β-oxidation [32,33]. Consequently, we
found the mRNA of FAS to be elevated in both ages of the HF
offspring. Fatty acid synthase is an intermediate enzyme that
uses acetyl-CoA and malonyl-CoA to form palmitic acid
(C16:0) in the process of fatty acid synthesis. Therefore, FAS
plays a role in energy metabolism and shows augmented
levels in association with NAFLD [34,35].The disruption in the mRNA expression of antioxidant
enzymesmay be associated with hepatic damage [36]. Studies
have found that oxidative stress may occur because of
increased ROS production and/or failure of the antioxidant
system. The antioxidant system is composed of nonenzy-
matic molecules and antioxidant enzymes such as MnSOD,
CAT, and GPx1 that react with and inactivate ROS [37].
Notably, a redox-centered pathogenesis is associated with
NAFLD, whereby the redox state/ROS may modulate lipid
metabolism and insulin sensitivity [38]. Indeed, oxidative
stress has been observed to precede IR [39].
It is important to highlight that epigenetic mechanisms
comprise several levels of interconnected and interdependent
codes, includingmethylation of DNA, covalentmodifications of
histones, and the gene-regulating and chromatin-organizing
activities of noncoding RNAs [40]. Such processes change the
binding of transcription activators and repressors to specific
gene promoters, and/or alter the large-scale conformation and
function of chromatin itself, which modulates gene expression
[41]. In addition, studies have associated obesity with DNA
hypermethylation of enzymes involved in mitochondrial fatty
acid oxidation, gluconeogenesis, and lipogenesis in the liver,
causing silencing of their expression and contributing to
obesity-induced liver IR [42,43].
Although we did not evaluate mitochondrial dysfunction,
a recent study reported an increase in mitochondrial complex
I and II activities, resulting in an increase in free radical
generation. The mitochondrial dysfunction associated with
reduced antioxidant capacity, together with reduced GPx1
expression, contributes to the pro-oxidative environment in
the offspring of DIO mothers later in life. Furthermore,
increased mitochondrial metabolism is associated with gen-
erated ROS with PPAR-γ activity and adipocyte differentiation
[44]. Our findings demonstrated a decrease in mRNA expres-
sion of CAT, MnSOD, and GPx1 from the day of birth to day 10
after birth. In addition, the analysis of antioxidant enzyme
activities in the 10 days offspring showed a reduction in the
SOD activity, whereas the activities of the CAT and GPx were
preserved, despite the reduced mRNA level observed to both
of the enzymes. An impairment of the hepatocyte antioxidant
defense mechanisms may have contributed to steatosis
development in the offspring because the protective capacity
of the hepatocytes to inhibit degradation induced by free
radicals was reduced [36].
In conclusion, the message of the current study is that of
DIO in maternal mice may induce an early oxidative
dysfunction coupled with hepatic steatosis in the offspring
that is measurable since the first days of life. Therefore, this
time may represent an interventional opportunity to prevent
liver damage progression and the development of metabolic
disorders later in life, such as IR.Financial support
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